Malignant Mesothelioma Mortality

Malignant mesothelioma is a fatal cancer primarily associated with exposure to asbestos; this mineral has been used in a wide variety of construction and manufacturing applications through most of the XX century. Although asbestos has been banned by UAE (at least for the building) in 2006, the mineral is still used for water pipilines and a substantial amount of asbestos remaining in buildings eventually will be removed, either during remediation or demolition. Maintenance, renovation, or demolition activities that might disturb asbestos should be performed with precautions that sufficiently prevent exposures for workers and the development of asbestos fibers in the air. In addition, physicians should document the occupational history of all suspected and confirmed mesothelioma cases.

In the United States, asbestos use peaked at 803,000 metric tons in 1973 and then declined to approximately 1,700 metric tons in 2007.

Most of these cancer cases, approximately 70 to 80 percent, are related to exposure of asbestos fibers.
The widespread use of asbestos during the XX Century led to an increase in the number of mesothelioma cases from the 1970s through the 1990s.

Currently approximately 2,000 to 3,000 malignant mesothelioma cases are diagnosed in the United States every year; in the period 1999-2005, a total of 18,068 deaths of persons with malignant mesothelioma were reported in the US, increasing from 2,482 deaths in 1999 to 2,704 in 2005.

One of the problem in those statistics is that the latency period between first exposure to asbestos and clinical disease usually is 20-40 years, but it may reach 50-60 years. The UAE were founded 40 years ago; and their development and the development of Dubai is even younger: it means we will be able to have information about mesothelioma cases in Dubai only in the future.

Some studies by dr. Stephen Swisher on resecting metastatic pulmonary tumors have been presented at the 2010 UAE Cancer Congress also. Swisher is board certified by the National Board of Medical Examiners, the American Board of Surgery and the American Board of Thoracic Surgery. He is currently a member of more than 20 professional organizations, including the American Association for Cancer Research, the American College of Surgeons Oncology Group and the American Society of Clinical Oncology.

Leave a Reply

Your email address will not be published. Required fields are marked *